Orphan Drug PricingOrphan Pricing, Rare-Disease Drug Pricing
The pricing strategies applied to rare disease treatments, frequently priced far higher per patient than common-condition treatments given the smaller patient population.
Terms for how medicine prices are set and negotiated and how patients gain access to new treatments.
The pricing strategies applied to rare disease treatments, frequently priced far higher per patient than common-condition treatments given the smaller patient population.
A pricing arrangement in which some or all payment for a treatment depends on it achieving predefined clinical outcomes in actual practice.
A formal agreement in which some or all of a treatment's payment is contingent on it achieving predefined clinical outcomes in practice.